MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Monday. The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 290,446 shares trading hands. The stock had previously closed at C$0.06.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 1.19, a quick ratio of 3.10 and a current ratio of 2.69. The business has a 50-day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.07. The stock has a market cap of C$25.63 million, a price-to-earnings ratio of -6.00 and a beta of -0.60.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Further Reading
- Five stocks we like better than MediPharm Labs
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
